SearchDictionaryMobileLogin Register FREE
Sample Data
from Research Interface

Activities of Daily Living (ADL)

4001  relevant articles (319 outcomes, 426 trials/studies) found for this Therapy

Description: The performance of the basic activities of self care, such as dressing, ambulation, eating, etc., in rehabilitation.

Also Known As:
ADL; Independent Living; Activities, Daily Living; Activity, Daily Living; Care, Self (Rehabilitation); Cares, Self (Rehabilitation); Daily Living Activities; Daily Living Activity; Living Activities, Daily; Living Activity, Daily; Living, Independent; Self Cares (Rehabilitation); Chronic Limitation of Activity; Limitation of Activity, Chronic; Self Care (Rehabilitation)

Relationship Network

Therapy Context: Research Results

Related Diseases

1.Pain (Aches)
2.Parkinson Disease (Parkinson's Disease)
3.Stroke (Strokes)
4.Alzheimer Disease (Alzheimer's Disease)
01/01/2004 - "It has been shown to provide significant benefits in cognition, global function and activities of daily living in patients with mild-to-moderate Alzheimer's disease"
01/01/2008 - "With repeated weekly dosing, sustained improvement at 1 month is documented, with a more than 10-point improvement in the patient's abilities to perform activities of daily living as measured by a standardized instrument, the Alzheimer's Disease Cooperative Study-Activities of Daily Living inventory"
07/01/2000 - "Using the Clinician's Global Rating of Change as a gold standard for change, differences between Bristol Activities of Daily Living Scale scores before and after medication were compared with change in Mini-Mental State Examination, Alzheimer's Disease Assessment Scale - Cognitive and the Nurses Observation Scale for Geriatric Patients, in 61 older adults receiving anticholinesterase medication for Alzheimer's disease"
05/01/1999 - "It benefited the cognitive decline, psychiatric and behavioral disturbances, impaired ability to perform instrumental and basic activities of daily living, and global state of patients diagnosed with mild-to-moderate Alzheimer's disease."
08/01/1998 - "Those drugs currently available, and those in development, may offer effective treatment for some of the core symptoms of Alzheimer's disease, slowing the rate of cognitive decline and preserving competence in activities of daily living for longer"
Get all the results and reference details, order at left...
5.Dyskinesias (Dyskinesia)
10/09/1997 - "RESULTS: The percent improvements at six months were as follows: off-period score for overall motor function, 28 percent (95 percent confidence interval, 19 to 38 percent), with most of the improvement in the contralateral limbs; off-period score for activities of daily living, 29 percent (95 percent confidence interval, 19 to 39 percent); on-period score for contralateral dyskinesias, 82 percent (95 percent confidence interval, 72 to 91 percent); and on-period score for ipsilateral dyskinesias, 44 percent (95 percent confidence interval, 29 to 59 percent)"
01/01/1998 - "At 6-month follow up, a cohort of our first 40 patients undergoing pallidotomy demonstrated the following mean improvements when examined after drug withdrawal (off) and under optimal medication (on): total motor off scores-31%; total off activities of daily living scores-30%; and total on dyskinesias-63% (contralateral and ipsilateral dyskinesias improved 82% and 50%, respectively)"
12/01/1990 - "During the course of this study, a statistically significant improvement was noted in percent "on" time, percent "on" time without dyskinesia, activity of daily living (ADL) scores during the "on" stages, and ADL, motor, and Schwab-England scores during the "off" stages"
10/01/2005 - "Stimulation improved cardinal features and activities of daily living (ADL) (P < 0.0001 and P < 0.02 for STN and GPi, respectively) and prolonged the 'on' time spent with good mobility without dyskinesias (P < 0.00001)"
07/01/2002 - "Three years postoperatively, GPi stimulation led to a significant improvement of dyskinesia severity (50%, P = 0.05) and activities of daily living (subscore of quality of life scale, 9%, P = 0.05)"
Get all the results and reference details, order at left...
497 Diseases and 4001 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.Levodopa (L Dopa)
2.donepezil (Aricept)
3.pramipexol (pramipexole)
4.Oxygen
5.Trichlorfon (Metrifonate)
6.Glucose (Dextrose)
7.Selegiline (E250)
8.ropinirole (Requip)
9.gabapentin (Neurontin)
10.Memantine (Namenda)
250 Drugs and Important Bio-Agents and 420 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.Activities of Daily Living (ADL)
2.Occupational Therapy (Therapy, Occupational)
3.Prostheses and Implants (Prosthesis)
4.Walking
5.Self-Help Devices (Assistive Technology)
114 Therapies and Procedures and 859 more articles analyzed in the Research Interface, order at left...

Research Interface Subscription

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Searches
  • 2 clicks from Disease to Drug to Evidence
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • Request Institution License details >>
Price:$490.00 access via web interface, 1 year subscription
Proceed to Checkout >>
Mobile Interface Subscription

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m", 1 year subscription
Proceed to Checkout >>